PHAT - Phathom Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PHAT is currently covered by 5 analysts with an average price target of $19.4. This is a potential upside of $10.67 (122.22%) from yesterday's end of day stock price of $8.73.

Phathom Pharmaceuticals's activity chart (see below) currently has 18 price targets and 61 ratings on display. The stock rating distribution of PHAT is 93.62% BUY and 6.38% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.21% with an average time for these price targets to be met of 39.63 days.

Highest price target for PHAT is $26, Lowest price target is $12, average price target is $19.4.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 13-Sep-2024.

Currently out of the existing stock ratings of PHAT, 44 are a BUY (93.62%), 3 are a HOLD (6.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$26

$17.22 (196.13%)

$26

2 months 7 days ago
(13-Sep-2024)

0/39 (0%)

$7.7 (42.08%)

Hold

$12

$3.22 (36.67%)

$10

3 months 11 days ago
(09-Aug-2024)

6/7 (85.71%)

$0.25 (2.13%)

29

Buy

$15

$6.22 (70.84%)

$22

1 years 8 months 19 days ago
(01-Mar-2023)

1/6 (16.67%)

$5.99 (66.48%)

152

Buy

$30

$21.22 (241.69%)

$35

1 years 8 months 19 days ago
(01-Mar-2023)

0/4 (0%)

$20.99 (232.96%)

Buy

$62

$52.74 (569.55%)

$50

3 years 1 months 3 days ago
(18-Oct-2021)

0/2 (0%)

$22.82 (77.64%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PHAT (Phathom Pharmaceuticals) average time for price targets to be met?

On average it took 39.63 days on average for the stock forecasts to be realized with a an average price target met ratio 23.21

Which analyst has the current highest performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?

PAUL CHOI

Which analyst has the current lower performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?

UMER RAFFAT

Which analyst has the most public recommendations on PHAT (Phathom Pharmaceuticals)?

Paul Choi works at GOLDMAN SACHS and has 15 price targets and 9 ratings on PHAT

Which analyst is the currently most bullish on PHAT (Phathom Pharmaceuticals)?

Prakhar Agrawal with highest potential upside - $52.74

Which analyst is the currently most reserved on PHAT (Phathom Pharmaceuticals)?

Umer Raffat with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?